Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,850.32 +1,528.09 (+2.34%) CMC Crypto 200
1,369.64 -4.20 (-0.31%)
Supernus Pharmaceuticals, Inc. (SUPN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.60B |
| Enterprise value | 1.34B |
| Trailing P/E | N/A |
| Forward P/E | 20.16 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.66 |
| Price/book (mrq) | 1.72 |
| Enterprise value/revenue | 2.25 |
| Enterprise value/EBITDA | 16.82 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | -15.70% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 35.96 |
| 52-week low 3 | 21.99 |
| 50-day moving average 3 | 31.49 |
| 200-day moving average 3 | 29.04 |
Share statistics
| Avg vol (3-month) 3 | 455.49k |
| Avg vol (10-day) 3 | 646.04k |
| Shares outstanding 5 | 54.97M |
| Implied shares outstanding 6 | 54.97M |
| Float 8 | 49.05M |
| % held by insiders 1 | 5.02% |
| % held by institutions 1 | 106.64% |
| Shares short (30 Apr 2024) 4 | 4.82M |
| Short ratio (30 Apr 2024) 4 | 14.05 |
| Short % of float (30 Apr 2024) 4 | 13.37% |
| Short % of shares outstanding (30 Apr 2024) 4 | 8.77% |
| Shares short (prior month 28 Mar 2024) 4 | 4.82M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -2.60% |
| Operating margin (ttm) | -2.96% |
Management effectiveness
| Return on assets (ttm) | 0.23% |
| Return on equity (ttm) | -1.68% |
Income statement
| Revenue (ttm) | 597.4M |
| Revenue per share (ttm) | 10.93 |
| Quarterly revenue growth (yoy) | -6.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 90.63M |
| Net income avi to common (ttm) | -15.51M |
| Diluted EPS (ttm) | -0.29 |
| Quarterly earnings growth (yoy) | -99.30% |
Balance sheet
| Total cash (mrq) | 297.74M |
| Total cash per share (mrq) | 5.42 |
| Total debt (mrq) | 42.13M |
| Total debt/equity (mrq) | 4.53% |
| Current ratio (mrq) | 1.73 |
| Book value per share (mrq) | 16.91 |
Cash flow statement
| Operating cash flow (ttm) | 100.36M |
| Levered free cash flow (ttm) | 588.32M |
© 2024 Yahoo. All rights reserved.